Crossmark

Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor

Crossref DOI link: https://doi.org/10.1007/s00044-022-02903-0

Published Online: 2022-05-12

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, Haozhou

Ma, Chunlong

Wang, Jun https://orcid.org/0000-0002-4845-4621
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (AI147325, AI157046, AI158775)
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 25 March 2022

Accepted: 2 May 2022

First Online: 12 May 2022

Compliance with ethical standards

:

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below